Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report.

Lee, Su Jin; Lee, Ho Sung; Choi, Jae Sung; Na, Ju Ock; Seo, Ki Hyun; Oh, Mi Hye; Jou, Sung Shick

Lee, Su Jin; Lee, Ho Sung; Choi, Jae Sung; Na, Ju Ock; Seo, Ki Hyun; Oh, Mi Hye; Jou, Sung Shick.

Afiliação

Lee SJ; Department of Internal medicine, Collage of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.

J Clin Med Res ; 4(3): 216-20, 2012 Jun.

Article em En | MEDLINE | ID: mdl-22719810

Palavras-chave

Gefitinib; Lepidic predominant adenocarcinoma; Retreatment

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376882
https://dx.doi.org/10.4021/jocmr816e

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Clin Med Res Ano de publicação: 2012 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376882
https://dx.doi.org/10.4021/jocmr816e

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Clin Med Res Ano de publicação: 2012 Tipo de documento: Article